A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)
PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment
55
Participants
Timeline
Start Date
Not specified
Study Completion Date
March 31, 1991
Conditions
AnemiaBlood TransfusionOrthopedic Procedures
Interventions
DRUG
epoetin alfa
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.